The founder of well-established British CBD brand Hempura has announced his plans to take the venture to the US market.
Known for its high-quality CBD products on this side of the pond, Hempura now wants to take its premium oils to the United States.
Launched in 2016, when the CBD market was still in its infancy, founder Lewis Hadaway quit his job in nuclear project management and started Hempura with his own funds, recognising the early potential in the market.
“I asked myself, ‘Is this the time for CBD?'” Hadaway said.
“I am still hands on, but in 2016 when I started the company, I did everything. I built the website. I set everything up. I was customer service. Everything has been meticulously designed by me.”
Now, Hadaway has a team in place, but the attention to detail is a core value at Hempura.
One reason Hadaway has emphasised education and information on Hempura’s website is the confusion that surrounds CBD.
“The CBD market is so saturated. Consumers don’t know what or who to believe,” he said.
“Consumers often are confused about CBD products. They don’t realise that you do not need blockbuster amounts of CBD to reap the benefits.
“What you need is a high-quality product made from natural hemp extract that contains different hemp compounds and terpenes. We set a high standard for our CBD products in the United Kingdom, which is the difference between Hempura CBD oil and other brands.”
Hempura now plans to export several of its broad-spectrum and full-spectrum CBD oil to the US.
Hadaway said Hempura emphasises education and customer service to slash through the confusion and stigma that still exists for some consumers.
“We provide transparency and educational information on our website so people can learn about CBD and its benefits,” he said, adding that Hempura offers authentic CBD products that people can trust.
The byproduct of Hempura’s approach is a loyal customer base.
“We build relationships with our customers because CBD is a lifelong product,” he said.
“We provide information and full transparency, so our customers understand why they are buying CBD. We empower our customers to make informed decisions. This reduces concerns and fears, especially for seniors.”
Ninety-five percent of the 617 reviews on Trust Pilot give Hempura a great or excellent rating.
“Excellent brand and service. Having tried a few other brands, Hempura was by far the best in terms of swift service and quality. I won’t be going anywhere else now,” Lizzy wrote on Trust Pilot.
Added Louise: “I cannot thank Hempura enough. Their customer service is exceptional. The staff is kind, polite, knowledgeable, and a pleasure to deal with … We have tried other oils but always return to Hempura and don’t plan to change anymore. It is a superior product.”
Hadaway said he appreciates the kind words from his customers.
“I am gratified that my original emphasis on education, quality, and customer service is embedded in our corporate culture,” he added.
“My team deserves the accolades. They all work hard to meet the needs of our customers.”
For more information, visit Hempura online.
- Malta gives green light to three new cannabis clubs
- European Commission must address ‘inequality’ in access to medicinal cannabis across EU
- 1 in 8 older US adults now use cannabis products, finds study
- 3 main contributors to the entourage effect for cannabis consumers to consider
- Medical cannabis doesn’t impair cognitive function – study
- Ukraine’s medical cannabis legalisation delayed by opponents
- News4 months ago
NHS approves major clinical trial on cannabis medicines and chronic pain
- News6 months ago
UK patient secures first NHS reimbursement for cannabis flowers
- Advocacy6 months ago
Inside a UK cannabis club: changing lives, tackling stigma, building community
- News4 months ago
UK research finds GP support for cannabis as an alternative to opioids for chronic pain
- Industry4 months ago
‘Landmark’ ruling gives hope for UK CBD flower businesses
- News4 months ago
Malta: Advocates emphasise positive effects of cannabis reform amid ‘normalisation’ concerns
- Science4 months ago
Five new cannabis studies – ALS, epilepsy, Parkinson’s, chronic pain and blood pressure
- Science6 months ago
New research suggests alcohol, not cannabis, is the real ‘gateway’ drug